Clinical Trial Update: Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)

View source ↗

Summary

Prospective SUMMIT Part 2 study applying deep phenotyping and machine learning to decipher age-related macular degeneration; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: University of Southampton | Conditions: Age-Related Macular Degeneration | Status: ENROLLING_BY_INVITATION